GB796069A - Substituted hydantoins - Google Patents

Substituted hydantoins

Info

Publication number
GB796069A
GB796069A GB3692255A GB3692255A GB796069A GB 796069 A GB796069 A GB 796069A GB 3692255 A GB3692255 A GB 3692255A GB 3692255 A GB3692255 A GB 3692255A GB 796069 A GB796069 A GB 796069A
Authority
GB
United Kingdom
Prior art keywords
methyl
aqueous
hydrindone
prepared
ethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB3692255A
Inventor
Wilson Shaw Waring
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Imperial Chemical Industries Ltd
Original Assignee
Imperial Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imperial Chemical Industries Ltd filed Critical Imperial Chemical Industries Ltd
Priority to GB3692255A priority Critical patent/GB796069A/en
Publication of GB796069A publication Critical patent/GB796069A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

The invention comprises substituted hydantoins of the general formula <FORM:0796069/IV (b)/1> wherein R1 and R2 represent hydrogen or methyl, ethyl or aryl radicals, and one of R3 and R4 represents hydrogen and the other a methyl or ethyl radical, and the preparation thereof in the case where R3 represents hydrol gen and R4 represents a methyl or ethyradical by alkylating hydontoin compounds of the general formula <FORM:0796069/IV (b)/2> wherein R1 and R2 have the above significance and in the case where R3 represents a methyl or ethyl radical and R4 represents hydrogen by reacting an hydrindene compound of the general formula <FORM:0796069/IV (b)/3> wherein R1 and R2 have the above significance and R3 represents a methyl or ethyl radical, and cyanic acid and hydrolysing the product in an acid medium, e.g. aqueous mineral acid such as aqueous hydrochloric acid. The latter process may be modified in that the hydrindene reactant is prepared by reacting the correponding a -hydrindone cyanohydrin and methylamine or ethylamine, e.g. a -hydrindone cyanohydrin itself may be reacted with methylamine. The alkylation step in the first process referred to above may be carried out with an alkyl sulphate, e.g. dimethyl sulphate, preferably in the presence of an aqueous or aqueous alcoholic alkaline medium such as aqueous alcoholic sodium hydroxide, or an alkyl halide, e.g. methyl or ethyl iodide, preferably in an alcoholic medium containing an alkali metal alkoxide such as an ethanolic metium containing sodium ethoxide. The latter process may also be modified in that the hydantoin reactant may be used in the form of a salt thereof such as the hydrochloride salt, and the cyanic acid is then used in the form of an alkali metal cyanate such as sodium cyanate. In the examples, 31-methylspirohydrindenyl - [1 : 51] - hydantoin, and the corresponding 1-methyl-, 31-ethyl-3 : 31-dimethyl-, 2 : 31-dimethyl- and 3-phenyl-31-methyl-compounds are prepared. Starting compounds. a -Hydrindone cyanohydrins of the general formula <FORM:0796069/IV (b)/4> wherein R1 and R2 have the above significance, are prepared by reacting the required a -hydrindone and hydrogen cyanaide or an alkali metal cyanide, e.g. sodium cyanide, in an aqueous medium. 2-Methylspirohydrindenyl-[1 : 51]-hydantoin is prepared by reacting 2-methyl-a -hydrindone, potassium cyanide and ammonium carbonate in aqueous ethanol, followed by acidification. 3-Phenylspirohydrindenyl-[1 : 51]-hydantoin is prepared by a similar method.
GB3692255A 1955-12-23 1955-12-23 Substituted hydantoins Expired GB796069A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB3692255A GB796069A (en) 1955-12-23 1955-12-23 Substituted hydantoins

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB3692255A GB796069A (en) 1955-12-23 1955-12-23 Substituted hydantoins

Publications (1)

Publication Number Publication Date
GB796069A true GB796069A (en) 1958-06-04

Family

ID=10392262

Family Applications (1)

Application Number Title Priority Date Filing Date
GB3692255A Expired GB796069A (en) 1955-12-23 1955-12-23 Substituted hydantoins

Country Status (1)

Country Link
GB (1) GB796069A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2415112A1 (en) * 1978-01-18 1979-08-17 Pfizer NEW SPIROTHIENOHYDANTOINS DERIVATIVES AND PHARMACEUTICAL COMPOSITION CONTAINING THEM
US4181728A (en) * 1978-11-16 1980-01-01 Pfizer Inc. Spiro-polycyclicimidazolidinedione derivatives
US4209630A (en) * 1976-10-18 1980-06-24 Pfizer Inc. Hydantoin derivatives as therapeutic agents
US4556670A (en) * 1982-12-06 1985-12-03 Pfizer Inc. Spiro-3-hetero-azolones for treatment of diabetic complications

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4209630A (en) * 1976-10-18 1980-06-24 Pfizer Inc. Hydantoin derivatives as therapeutic agents
FR2415112A1 (en) * 1978-01-18 1979-08-17 Pfizer NEW SPIROTHIENOHYDANTOINS DERIVATIVES AND PHARMACEUTICAL COMPOSITION CONTAINING THEM
US4181728A (en) * 1978-11-16 1980-01-01 Pfizer Inc. Spiro-polycyclicimidazolidinedione derivatives
US4556670A (en) * 1982-12-06 1985-12-03 Pfizer Inc. Spiro-3-hetero-azolones for treatment of diabetic complications

Similar Documents

Publication Publication Date Title
GB869776A (en) Isobutyrophenone compounds and the production thereof
GB796069A (en) Substituted hydantoins
GB934017A (en) Color formers for producing yellow dye images by color development
GB1489803A (en) Aminoacetamides and a process for their preparation
GB949725A (en) Phenylalanine derivatives
ES370120A1 (en) Chromanes
US2872454A (en) Spiro-hydantoins from x-chloro-
GB1366004A (en) Bis-s-triazinylamino-stilbene-2 2-disulphonic acids
HU902080D0 (en) Process for producing substituted ethylenes
GB787061A (en) Process for producing n-methyl--a-phenylsuccinimide
GB807679A (en) New substituted hydantoin and thiohydantoin
GB807678A (en) New substituted hydantoins and thiohydantoins
GB752692A (en) Improvements in aminoacetic acid derivatives
GB818724A (en) Hydantoin derivatives
GB1384486A (en) N-alkyl-n-o-tolylanthranilonitriles and their use in the preparation of 5-alkyl-10-amino-dihydrodibenzoazepines
GB1199614A (en) Process for Producing 2-Amino-4-Substituted Butyric Acids and the Corresponding Hydantoins
GB817745A (en) 2-thiohydantoins
GB999595A (en) Improvements in or relating to oximes and the manufacture thereof
GB1041015A (en) Improvements in or relating to spiropiperidyl-succinimide derivatives
GB1476294A (en) Thiophene or furan derivatives and process for preparation thereof
GB1226893A (en)
GB774018A (en) Method of making 2-tertiarybutyl-4-alkoxy-phenols
GB890732A (en) Improvements in or relating to diphenylamines
GB1030391A (en) Improvements in or relating to intermediates of use in the production of cephalosporins
GB755203A (en) Improvements in or relating to basically substituted carboxylic acid amides